Literature DB >> 35543523

Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy.

Kelsea Zukauckas1, Russell J Benefield1, Michael Newman2, Laura Certain3.   

Abstract

Entities:  

Keywords:  OPAT; adverse drug reactions; beta-lactam

Mesh：

Substances：

Year:  2022        PMID： 35543523      PMCID： PMC9211408          DOI： 10.1128/aac.00579-22

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


× No keyword cloud information.
  10 in total

1.  The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Danielle Ciuffetelli; Warren Bilker; Anne Norris; Daniel Timko; Alex Rosen; Jennifer S Myers; Janet Hines; Joshua Metlay
Journal:  J Pharm Technol       Date:  2013-10

2.  2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.

Authors:  Anne H Norris; Nabin K Shrestha; Genève M Allison; Sara C Keller; Kavita P Bhavan; John J Zurlo; Adam L Hersh; Lisa A Gorski; John A Bosso; Mobeen H Rathore; Antonio Arrieta; Russell M Petrak; Akshay Shah; Richard B Brown; Shandra L Knight; Craig A Umscheid
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

3.  Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.

Authors:  Daniel Huck; Jennifer P Ginsberg; Steven M Gordon; Amy S Nowacki; Susan J Rehm; Nabin K Shrestha
Journal:  J Antimicrob Chemother       Date:  2013-07-25       Impact factor: 5.790

4.  Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics.

Authors:  Kimberly G Blumenthal; Ilan Youngster; Dustin J Rabideau; Robert A Parker; Karen S Manning; Rochelle P Walensky; Sandra B Nelson
Journal:  J Allergy Clin Immunol       Date:  2015-05-14       Impact factor: 10.793

5.  A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).

Authors:  Eavan G Muldoon; Karen Switkowski; Alan Tice; David R Snydman; Geneve M Allison
Journal:  Infect Dis (Lond)       Date:  2014-11-21

6.  Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.

Authors:  Punit J Shah; Scott J Bergman; Donald R Graham; Stephanie Glenn
Journal:  J Pharm Pract       Date:  2014-08-08

Review 7.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

Authors:  R C Bone; R A Balk; F B Cerra; R P Dellinger; A M Fein; W A Knaus; R M Schein; W J Sibbald
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

8.  Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Ayse P Gurses; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

9.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.

Authors:  Rinaldo Bellomo; Claudio Ronco; John A Kellum; Ravindra L Mehta; Paul Palevsky
Journal:  Crit Care       Date:  2004-05-24       Impact factor: 9.097
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.